Windlas Biotech IPO Details

Windlas Biotech IPOWindlas Biotech IPO description – Windlas Biotech is amongst the top five players in the domestic pharmaceutical formulations contract development and manufacturing organization (CDMO) industry in India in terms of revenue. In FY 2020, the company’s market share was approximately 1.5% in terms of revenue in the domestic formulations CDMO industry. In addition to providing services and products in the CDMO market, the company also sells its own branded products in the trade generics and OTC markets as well as export generic products to several countries.

The company has significant experience in developing and manufacturing generic fixed dose combinations. Its focus has currently been on launching new complex generic products in the chronic therapeutic category linked to lifestyle related disorders. Its complex generic products portfolio primarily comprises fixed dosage combinations, fixed dosage plus modified release combinations, customized generics and chewable or dispersible, which was 68.5% of its total product portfolio in FY2021. Windlas Biotech operates three distinct strategic business verticals (SBVs): (i) CDMO Services and Products; (ii) Domestic Trade Generics and over-the-counter (OTC) Brands; and (iii) Exports.

Promoters of Windlas Biotech – Ashok Kumar Windlass, Hitesh Windlass, Manoj Kumar Windlass and AKW WBL Family Private Trust
Windlas Biotech IPO details
Subscription Dates 4 – 6 August 2021
Price Band INR448 – 460 per sshare
Fresh issue INR165 crore
Offer For Sale 5,142,067 shares (INR230.36 – 236.53 crore)
Total IPO size INR395.36 – 401.53 crore
Minimum bid (lot size) 30 shares
Face Value  INR5 per share
Retail Allocation 35%
Listing On NSE, BSE

Windlas Biotech Financial Performance (in INR crore)

FY2019 FY2020 FY2021
Revenue 311.5 331.3 430.7
Expenses 284.2 299.2 387.2
Net income 63.7 16.0 15.9
Margin (%) 20.4 4.8 3.7

More about Windlas Biotech IPO

Registrar of Windlas Biotech IPO

Link Intime India Private Limited
C-101, 1st Floor,
247 Park Lal Bahadur Shastri Marg, Vikhroli (West) Mumbai – 400 083
Phone: +91 22 4918 6200
Fax: +91 22 4918 6195
Email: [email protected]

Windlas Biotech Contact Details

Windlas Biotech Limited
705-706, Vatika Professional Point, Sector-66, Golf Course Extension Road, Gurgaon 122 001, Haryana
Phone: +91 124 2821030
Email: [email protected]

Valuation of Windlas Biotech (as of FY2021)

Earnings Per Share (EPS): INR8.70
Price/Earnings (PE ratio): 51.49 – 52.87
Return on Net Worth (RONW): 18.19%
Net Asset Value (NAV): INR109.36 per share

Windlas Biotech IPO GMP Daily Trend

Date Windlas Biotech IPO GMP Kostak Subject to Sauda
14 August 2021 INR80
13 August 2021 INR80
12 August 2021 INR75
11 August 2021 INR60
10 August 2021 INR70
9 August 2021 INR70
7 August 2021 INR80 Few trades Few trades
6 August 2021 INR80 Few trades Few trades
5 August 2021 INR110 Few trades Few trades
4 August 2021 INR120 Few trades Few trades
3 August 2021 INR100 Few trades Few trades
2 August 2021 INR120 Few trades Few trades
31 July 2021 INR120 Few trades Few trades
30 July 2021 INR150

Windlas Biotech IPO Subscription Details

Category Shares offered Subscription (no. of times, at 5 PM)
Day 1 Day 2 Day 3
QIB 17,23,700 0.00 0.04 24.40
NII 13,23,766 0.34 1.11 15.73
Retail 30,88,786 6.12 13.40 24.10
Total 61,36,252 3.15 6.99 22.38

Windlas Biotech IPO Reviews

Angel Broking – Subscribe
Anand Rathi –
Antique Stock Broking –
Arihant Capital –
Ashika Research –
AUM Capital –
BP Wealth – Subscribe
Canara Bank Securities –
Choice Broking – Subscribe for long term
Elite Wealth – Listing gains
Hem Securities – Subscribe
ICICIdirect – Unrated
Marwadi Financial Services – Subscribe
Motilal Oswal –
Nirmal Bang –
Prabhudas Lilladher –
Ventura Securities – Subscribe

Windlas Biotech IPO Allotment Status

Windlas Biotech IPO allotment is now available on Link Intime’s website. Click on this link to get allotment status.

Listing Performance of Windlas Biotech

IPO Opening Date: 4 August 2021
IPO Closing Date: 6 August 2021
Finalisation of Basis of Allotment: 11 August 2021
Initiation of refunds: 12 August 2021
Transfer of shares to demat accounts: 13 August 2021
Listing Date: 16 August 2021
Opening Price on NSE: INR437 per share (down 5% from IPO price)
Closing Price on NSE: INR406 per share (down 11.74% from IPO price)


Please enter your comment!
Please enter your name here

Free IPO Investing With India's Leading Broker